Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/difference-in-sars-cov-2-antibody-status-between-patients-with-cancer-w21JZgeyq6
References (33)
-
H. Läubli, C. Balmelli, Lukas Kaufmann, Michal Stanczak, Mohammedyaseen Syedbasha, Dominik Vogt, A. Hertig, B. Müller, O. Gautschi, F. Stenner, A. Zippelius, A. Egli, S. Rothschild (2018)
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse eventsJournal for Immunotherapy of Cancer, 6
-
Rudragouda Channappanavar, Brandon Twardy, S. Suvas (2012)
Blocking of PDL-1 Interaction Enhances Primary and Secondary CD8 T Cell Response to Herpes Simplex Virus-1 InfectionPLoS ONE, 7
-
Jing Yu, Ouyang Wen, M. Chua, C. Xie (2020)
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 6
-
J. Deeks, J. Dinnes, Y. Takwoingi, C. Davenport, R. Spijker, S. Taylor-Phillips, Ada Adriano, S. Beese, J. Dretzke, Lavinia Ruffano, I. Harris, M. Price, S. Dittrich, D. Emperador, L. Hooft, M. Leeflang, A. Bruel (2020)
Antibody tests for identification of current and past infection with SARS‐CoV‐2The Cochrane Database of Systematic Reviews, 2020
-
S. Lumley, D. O’Donnell, N. Stoesser, P. Matthews, A. Howarth, S. Hatch, B. Marsden, S. Cox, T. James, F. Warren, Liam Peck, Thomas Ritter, Z. Toledo, L. Warren, D. Axten, R. Cornall, E. Jones, D. Stuart, G. Screaton, D. Ebner, S. Hoosdally, M. Chand, D. Crook, A. O'donnell, C. Conlon, K. Pouwels, A. Walker, T. Peto, S. Hopkins, T. Walker, K. Jeffery, D. Eyre (2020)
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersThe New England Journal of Medicine
-
J. Rogado, B. Obispo, C. Pangua, G. Serrano-Montero, A. Marino, M. Pérez-Pérez, A. López-Alfonso, P. Gullón, M. Lara (2020)
Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in MadridClinical & Translational Oncology, 22
-
V. Mehta, S. Goel, R. Kabarriti, Daniel Cole, M. Goldfinger, A. Acuna-Villaorduna, K. Pradhan, R. Thota, S. Reissman, J. Sparano, B. Gartrell, Richard Smith, N. Ohri, M. Garg, A. Racine, S. Kalnicki, R. Perez-soler, B. Halmos, A. Verma (2020)
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemCancer Discovery, 10
-
(2013)
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.JAMA, 310 20
-
F. Polack, Stephen Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, John Perez, Gonzalo Marc, E. Moreira, C. Zerbini, R. Bailey, K. Swanson, Satrajit Roychoudhury, K. Koury, Ping Li, W. Kalina, D. Cooper, R. Frenck, L. Hammitt, Ö. Türeci, H. Nell, A. Schaefer, S. Ünal, D. Tresnan, S. Mather, P. Dormitzer, U. Şahin, K. Jansen, W. Gruber (2020)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine
-
Patel (2020)
140MMWR Morb Mortal Wkly Rep, 69
-
T. Fuereder, A. Berghoff, G. Heller, H. Haslacher, T. Perkmann, R. Strassl, J. Berger, H. Puhr, J. Kreminger, F. Moik, Lorenz Schubert, A. Starzer, A. Steindl, S. Winkler, M. Preusser, S. Tobudic (2020)
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemicESMO Open, 5
-
Ann-Sofie Rudberg, S. Havervall, A. Månberg, A. Falk, K. Aguilera, H. Ng, Lena Gabrielsson, A. Salomonsson, L. Hanke, B. Murrell, G. McInerney, J. Olofsson, E. Andersson, C. Hellström, Shaghayegh Bayati, Sofia Bergström, E. Pin, R. Sjöberg, Hanna Tegel, M. Hedhammar, M. Phillipson, P. Nilsson, S. Hober, C. Thålin (2020)
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in SwedenNature Communications, 11
-
Mengyuan Dai, Dianbo Liu, Miao Liu, F. Zhou, Guiling Li, Zhen Chen, Zhi-An Zhang, Hua You, Meng Wu, Qichao Zheng, Y. Xiong, H. Xiong, Chun Wang, Changchun Chen, F. Xiong, Yan Zhang, Yaqin Peng, S. Ge, Bo Zhen, Tingting Yu, Ling Wang, Hua Wang, Yu Liu, Yeshan Chen, Jun-hua Mei, Xiaojia Gao, Zhuyan Li, Lijuan Gan, Can He, Zhen Li, Yuying Shi, Y. Qi, Jing Yang, D. Tenen, L. Chai, L. Mucci, M. Santillana, H. Cai (2020)
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakCancer Discovery, 10
-
J. Moscola, Grace Sembajwe, M. Jarrett, B. Farber, Tylis Chang, T. McGinn, K. Davidson (2020)
Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.JAMA
-
F. Anelli, Giovanni Leoni, R. Monaco, Cosimo Nume, Roberto Rossi, G. Marinoni, G. Spata, D. Giorgi, Luigi Peccarisi, A. Miani, E. Burgio, I. Gentile, A. Colao, M. Triassi, P. Piscitelli (2020)
Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreakBMJ, 368
-
A. Berghoff, M. Gansterer, A. Bathke, W. Trutschnig, P. Hungerländer, J. Berger, J. Kreminger, A. Starzer, R. Strassl, R. Schmidt, H. Willschke, W. Lamm, M. Raderer, A. Gottlieb, N. Mauser, M. Preusser (2020)
SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
A. García-Basteiro, G. Moncunill, M. Tortajada, M. Vidal, C. Guinovart, A. Jiménez, R. Santano, S. Sanz, S. Méndez, A. Llupià, R. Aguilar, S. Alonso, D. Barrios, C. Carolis, P. Cisteró, E. Chóliz, A. Cruz, S. Fochs, C. Jairoce, J. Hecht, M. Lamoglia, Mikel Martínez, R. Mitchell, N. Ortega, N. Pey, L. Puyol, Marta Ribes, N. Rosell, P. Sotomayor, S. Torres, S. Williams, Sónia Barroso, A. Vilella, J. Muñoz, A. Trilla, P. Varela, A. Mayor, C. Dobaño (2020)
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospitalNature Communications, 11
-
H. Miyashita, Takahisa Mikami, N. Chopra, Takayuki Yamada, S. Chernyavsky, D. Rizk, Christina Cruz (2020)
Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York CityAnnals of Oncology, 31
-
W. Liang, W. Guan, Ruchong Chen, Wei Wang, Jianfu Li, Ke Xu, Caichen Li, Qing Ai, Weixiang Lu, Hengrui Liang, Shiyue Li, Jianxing He (2020)
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet. Oncology, 21
-
B. Rousseau, P. Loulergue, O. Mir, A. Krivine, S. Kotti, E. Viel, T. Simon, A. Gramont, F. Goldwasser, O. Launay, C. Tournigand (2012)
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.Annals of oncology : official journal of the European Society for Medical Oncology, 23 2
-
L. Baden, H. Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, S. Spector, N. Rouphael, C. Creech, J. Mcgettigan, Shishir Kehtan, N. Segall, Joel Solis, A. Brosz, C. Fierro, H. Schwartz, K. Neuzil, L. Corey, P. Gilbert, H. Janes, D. Follmann, M. Marovich, J. Mascola, L. Polakowski, J. Ledgerwood, B. Graham, H. Bennett, R. Pajon, C. Knightly, B. Leav, W. Deng, Honghong Zhou, Shu Han, M. Ivarsson, Jacqueline Miller, T. Zaks (2020)
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine
-
D. Steensels, E. Oris, L. Coninx, D. Nuyens, M. Delforge, P. Vermeersch, L. Heylen (2020)
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium.JAMA
-
L. Cabezón-Gutiérrez, S. Custodio-Cabello, Magda Palka-Kotlowska, Eduardo Oliveros-Acebes, M. García-Navarro, P. Khosravi-Shahi (2020)
Seroprevalence of SARS-CoV-2–specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available dataCancer Treatment Reviews, 90
-
Anita Patel, D. Jernigan (2020)
Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak — United States, December 31, 2019–February 4, 2020American Journal of Transplantation, 20
-
QuanQiu Wang, N. Berger, Rong Xu (2020)
Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.JAMA oncology
-
K. Noda, K. Matsuda, S. Yagishita, K. Maeda, Y. Akiyama, Junko Terada-Hirashima, H. Matsushita, S. Iwata, K. Yamashita, Y. Atarashi, Shunsuke Watanabe, N. Ide, Tomokazu Yoshida, N. Ohmagari, H. Mitsuya, A. Hamada (2021)
A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodiesScientific Reports, 11
-
M. Pollán, Beatriz Pérez-Gómez, R. Pastor-Barriuso, J. Oteo, Miguel Hernán, M. Pérez-Olmeda, J. Sanmartín, Aurora Fernández-García, Israel Cruz, N. Larrea, Marta Molina, F. Rodríguez-Cabrera, Mariano Martín, P. Merino-Amador, José Paniagua, Juan Muñoz-Montalvo, Faustino Blanco, R. Yotti, Faustino M, Faustino Blanco, Rodrigo Fernández, Mariano Martín, Saturnino Navarro, Marta Molina, Juan Muñoz-Montalvo, Matías Hernández, J. Sanmartín, M. Cuenca‐Estrella, R. Yotti, José Paniagua, N. Larrea, P. Fernández-Navarro, R. Pastor-Barriuso, Beatriz Pérez-Gómez, M. Pollán, A. Avellón, G. Fedele, Aurora Fernández-García, Jesus Iglesias, María Olmeda, Israel Cruz, M. Martinez, F. Rodríguez-Cabrera, Miguel Hernán, Susana Fernández, J. Aguirre, J. Marí, B. Borrás, A. Jiménez, M. Rodriguez-Iglesias, Ana Gascón, M. Alcaine, I. Suárez, Óscar Álvarez, Mercedes Pérez, Margarita Sanchís, Carlos Gomila, L. Saladrigas, Adoración Fernández, A. Oliver, Elías Feliciano, María Quintana, José Fernández, María Betancor, M. Febles, L. Martín, Luis-Mariano López, Teresa Miota, Inés Población, María Pérez, M. Fernández, Tomás Enríquez, Miguel Arranz, M. González, I. Fernández-Natal, Gregoria Lobón, J. Bellido, P. Ciruela, Ariadna Casals, Maria Botías, M. Maeso, D. Campo, Antonio Castro, Ramón Ramírez, Maria Retamosa, M. González, María Lobeiras, Alberto Losada, A. Aguilera, G. Bou, Yolanda Caro, Noemí Marauri, Luis Blanco, I. González, M. Pascual, R. Fernández, P. Merino-Amador, Natalia Castro, Aurora Lizcano, C. Almagro, M. Hernández, N. Elizaga, M. Sanz, C. Baquedano, Ana Bascaran, Susana Tamayo, Luis Otazua, Rebeca Benarroch, Jesús Flores, A. Villa (2020)
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological studyLancet (London, England), 396
-
R. Verma, R. Foster, K. Horgan, Katherine Mounsey, Helen Nixon, N. Smalle, T. Hughes, C. Carter (2016)
Lymphocyte depletion and repopulation after chemotherapy for primary breast cancerBreast Cancer Research : BCR, 18
-
P. Loulergue, J. Alexandre, I. Iurisci, S. Grabar, J. Medioni, S. Ropert, V. Diéras, F. Chevalier, S. Oudard, F. Goldwasser, P. Lebon, O. Launay (2011)
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot studyBritish Journal of Cancer, 104
-
M. Solodky, C. Galvez, B. Russias, P. Detourbet, V. N’Guyen-Bonin, A. Herr, P. Zrounba, J. Blay (2020)
Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19Annals of Oncology, 31
-
A. Bertuzzi, A. Marrari, N. Gennaro, U. Cariboni, M. Ciccarelli, L. Giordano, V. Quagliuolo, A. Santoro (2020)
Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, ItalyCancers, 12
-
R. Park, Sul Lee, Seong-Yoon Kim, A. Melo, A. Kasi (2020)
Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient dataActa Oncologica, 60
-
N. Fillmore, J. La, R. Szalat, D. Tuck, V. Nguyen, C. Yildirim, N. Do, M. Brophy, N. Munshi (2020)
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs StudyJNCI Journal of the National Cancer Institute, 113
- Publisher
- American Medical Association
- Copyright
- Copyright 2021 American Medical Association. All Rights Reserved.
- ISSN
- 2374-2437
- eISSN
- 2374-2445
- DOI
- 10.1001/jamaoncol.2021.2159
- Publisher site
- See Article on Publisher Site
Abstract
Key PointsQuestionAre there differences in seroprevalence and antibody levels for SARS-CoV-2 between patients with cancer and health care workers (HCWs) during the COVID-19 pandemic in Japan? FindingsIn this cross-sectional study including 500 patients with cancer and 1190 HCWs, the seroprevalence was 1.0% in patients and 0.67% in HCWs. However, the levels of IgG antibodies against nucleocapsid and spike protein were significantly lower in patients than in HCWs. MeaningThese findings indicate that seroprevalence was not different in patients with cancer compared with HCWs, but the immune response to SARS-CoV-2 may differ between patients with cancer and HCWs.
Journal
JAMA Oncology – American Medical Association
Published: Aug 28, 2021